IJR News — today's news from every side
+19 Chris Dalton Restoring some mouse behavior is interesting but it probably won't translate cleanly to fixing actual human brain problems anytime soon.Dr. David Crean Book Guides Biopharma Leaders on Commercialization x/david-crean — Sep 18, 2026 A new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC. +5 Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.+19 Rachel Meyers Holding steady makes sense when you can't even hit current targets, let alone increase them with Hormuz tensions this high.+9 Sam Okafor The Hebrew and Greek nuance stuff is fascinating but I worry books like this can just become another way to argue whose interpretation is the correct one.
